Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating whether consolidative involved-site radiotherapy improves outcomes in patients with limited-stage follic…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma [Phase 3]
A Phase 3 clinical trial assesses the efficacy of low-dose palliative involved-field radiation therapy for recurrent advanced follicular lym…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: A Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular Lymphoma [Phase 3]
A Phase 3 study evaluating long-term rituximab maintenance therapy in participants with advanced follicular lymphoma, with results posted in…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 retreatment study of Galiximab plus Rituximab for follicular non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001) [Phase 1]
Phase 1 trial for MK-8808 in follicular lymphoma was terminated; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Non-interventional study update on rituximab treatment in follicular lymphoma; study completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma [Phase 2]
A Phase 2 study evaluating rituximab in combination with GM-CSF in patients with follicular B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 study of GS-9901 in adults with relapsed or refractory follicular lymphoma, marginal zone lymphoma, chronic lymphocytic leukemia, or…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 trial of Galiximab plus Rituximab versus Rituximab plus placebo in follicular non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Clinical trial update reporting results of rituximab in combination with chemotherapy for follicular lymphoma (REFLECT 1).
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 study sponsored by the National Cancer Institute evaluating dasatinib in patients with metastatic or unresectable solid tumors and l…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of MGCD0103 in combination with azacitidine (Vidaza) for relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial completion evaluating a fusion protein cytokine therapy after Rituximab in patients with B-cell non-Hodgkin lymphomas.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma [Phase 2]
Phase 2 trial evaluating epigenetic modulation in relapsed/refractory follicular lymphoma and marginal zone lymphoma was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma [Phase 1]
This update notes the completion of a Phase 1 trial evaluating vaccine therapy plus interleukin-2 in patients with follicular lymphoma.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update reporting completion of a study evaluating interleukin-12 in patients with various previously treated non-Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL [Phase 1, Phase 2]
A Phase 1/2 trial of rituximab plus CAMPATH in relapsed/refractory CD20-positive B-cell non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers [Phase 1]
First-in-human Phase 1 trial assessing safety, tolerability, and preliminary efficacy of an anti-CXCR4 antibody in acute myeloid leukemia an…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies [Phase 2]
A Phase 2 feasibility study evaluating a 60-minute rapid infusion rituximab protocol in patients with indolent or intermediate-grade B-cell …
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab, cyclophosphamide, bortezomib, and dexamethasone in relapsed/refractory low-grade follicular lym…